Neuroglee Therapeutics
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $10M
Investors
- 2
About Neuroglee Therapeutics
Based in Singapore, Neuroglee Therapeutics, Inc.Founded in 2020 and headquartered in Singapore, Neuroglee Therapeutics Pte. Ltd. specializes in cognitive health solutions, notably offering digital programs for dementia care. The CEO and founder, Aniket Rajput, leads the company's efforts in transforming memory care services.Neuroglee Health specializes in comprehensive memory and dementia care services designed to enhance the quality of life for individuals experiencing cognitive decline and support their care partners. The core offerings include clinically proven cognitive support programs accessible through a digital platform, developed in collaboration with leading healthcare institutions like the Mayo Clinic. The services address challenges faced by patients with memory impairment and dementia, providing tailored strategies that include symptom management, cognitive exercises, and nutritional guidance.Neuroglee Health generates revenue through a value-based care model that fosters partnerships with healthcare organizations, offering subscription-based access to its platform for both patients and care providers. The transactions often involve service agreements where health plans and provider groups pay for access to the platform, which includes continuous clinical support and monitoring. The company's flagship services aim to create measurable improvements in cognitive health, thereby reducing long-term care costs. Clients engage in a B2B transaction model, providing access to their patients under structured plans that align incentives for improved care delivery. Specific pricing plans and further financial arrangements are tailored to the needs of each partnership, ensuring a sustainable revenue stream.In September 2021, Neuroglee Therapeutics Pte. Ltd.S.
Who invested in Neuroglee Therapeutics
2 investors across 1 round
See all investors in Neuroglee Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 9, 2021
Amount
$10M
Investors
Questions about Neuroglee Therapeutics
Who invested in Neuroglee Therapeutics?
Neuroglee Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neuroglee Therapeutics raised?
Neuroglee Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neuroglee Therapeutics last raise money?
Neuroglee Therapeutics's most recent round on record is a Series A, in Sep 2021.
What does Neuroglee Therapeutics do?
Based in Singapore, Neuroglee Therapeutics, Inc.
Where is Neuroglee Therapeutics headquartered?
Neuroglee Therapeutics is headquartered in Singapore, Singapore.
Which VCs invest in companies like Neuroglee Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Neuroglee Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Neuroglee Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.